Viewing nowCombinationNewStatJet R Tablet 10/20 mg
Rosuvastatin Calcium 20.8mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Samjin Pharmaceutical Co., Ltd.

MFDS item code 202004606 · Approved 2020.06.23 · Insurance code 647805020
For the treatment of primary hypercholesterolemia and mixed dyslipidemia
This medication serves to supplement diet in lowering high total cholesterol, LDL-cholesterol, Apo B protein, triglyceride, and non-HDL cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia, as well as to raise HDL cholesterol levels. Particularly in patients at increased risk of atherosclerotic vascular disease, multiple risk factors should be taken into account when using lipid-lowering medication. Furthermore, this medication should be used alongside appropriate dietary restrictions such as limiting saturated fats and cholesterol, and is administered when dietary treatment alone is insufficient. Before treatment, it is vital to identify and treat other causes of dyslipidemia, such as diabetes and hypothyroidism. During treatment, total cholesterol, LDL, HDL, and triglyceride levels should be regularly monitored and managed appropriately. This medication helps improve patients' blood lipid levels and reduce the risk of cardiovascular disease.
This medicine is administered once daily, regardless of meals. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response to treatment. Primary hypercholesterolemia The dose range is 10/5mg to 10/20mg once daily. The recommended starting dose is 10/5mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting treatment or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose adjusted accordingly. The dose may be increased to a maximum of 10/20mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.
This medication can rarely cause a serious muscle disorder called rhabdomyolysis, which may lead to acute renal failure. Patients with conditions that can exacerbate muscle damage, such as severe infection, hypotension, major surgery, trauma, or severe metabolic disorders, should temporarily discontinue or stop this medication. This medication should not be administered to patients allergic to the active ingredient or any components, patients with active liver disease, patients with muscle disorders, patients with severe renal failure, or women who are pregnant or breastfeeding. Patients at high risk of myopathy, such as those with impaired kidney function, hypothyroidism, a history of muscle disorders, elderly individuals, and alcoholics, should use this medication with caution. If symptoms of muscle pain, cramps, or weakness occur during treatment, patients should promptly inform their physician and undergo examination; in severe cases, the medication should be discontinued. Abnormal liver function may occur, so liver function tests should be performed before treatment, and if signs of liver damage appear during treatment, tests should be repeated. If liver enzyme levels remain elevated, dose adjustment or discontinuation may be necessary. This medication may raise blood sugar levels, so patients at risk of diabetes should regularly monitor their blood sugar. Caution is advised when co-administering with other medications, especially anticoagulants, fibrates, some antibiotics, antifungal agents, and immunosuppressants. Women who are pregnant or may become pregnant must use effective contraception while taking this medication and should discontinue it immediately if pregnancy is confirmed. Safety in children and adolescents has not been adequately established, so it is not recommended for pediatric use. Elderly patients are at higher risk of myopathy, requiring careful observation during use. This medication should be stored out of reach of children, and should not be transferred to other containers.
Acute renal failure due to myoglobinuria, rhabdomyolysis, nasopharyngitis, dyspepsia, elevation of ALT, edema, myalgia, elevation of AST, headache, acute pyelonephritis, dry mouth, elevation of liver enzymes, abnormal liver function tests, increased serum lactate dehydrogenase, pruritus, upper respiratory tract infection, increased blood sugar, increased serum CPK, biliary disorders, chest pain, facial edema, strange sensations, drug intolerance, colon polyps, irritable bowel syndrome, esophagitis, dizziness, drowsiness, neurodegenerative disorders, orthostatic dizziness, migraines, diabetes, impaired glucose tolerance, depression, bronchitis, rhinitis, cystitis, fungal infections of nails and skin, soft tissue infections, fatty liver, liver impairment, hepatic toxicity, acute hepatitis, toxic hepatitis, increased gamma-glutamyl transferase, increased blood cholesterol, increased serum alkaline phosphatase, irregular heart rate, osteoarthritis, osteoporosis, musculoskeletal stiffness, musculoskeletal discomfort, muscle weakness, sweating, dermatitis, skin burning sensation, skin disorders, alopecia, oropharyngeal pain, nasal congestion, respiratory disorders, pelvic pain, breast cysts, ptosis, diabetic retinopathy, ear discomfort, renal dysfunction, benign esophageal neoplasm, vascular edema, diabetes, headaches, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myopathy, rhabdomyolysis, asthenia, thrombocytopenia, jaundice, hepatitis, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, memory decline, forgetfulness, amnesia, memory disorders, confusion, severe muscle weakness, ocular myasthenia, increased CK, chest pain, chest discomfort, systemic edema, diabetic neuropathy, tremors, upper abdominal pain, vomiting, gastritis, xerostomia, epigastric discomfort, belching, gastrointestinal disorders, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, cough, phlegm, rhinorrhea, limb pain, arthralgia, hypoglycemia, anemia, splenomegaly, urticaria, hyperhidrosis, conjunctival congestion, renal failure, liver dysfunction, increased serum creatinine, elevated blood pressure, increased blood urea, muscle cramps, gout, erectile dysfunction
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from exposure to air or moisture, and it is important to maintain a storage temperature between 1 to 30 degrees Celsius. Proper storage will help to maintain the medication's efficacy for a longer period.
Pink oval film-coated tablet
30 tablets/box [10 tablets/PTP*3], 30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationRosuvastatin Calcium 20.8mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Samjin Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Albozen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Albogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Albogene Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.